Can anyone remember the language on the second to last slide -- showing the 4th quarter of this year time when SOMETHING WOULD HAPPEN regarding "timing" of ICI option in the current CRC trial -- was that when THIS WOULD BE CONSIDERED by the FDA, or what?

Sorry I didn't get it exactly! NJ might know.